Vaccination with plasmid DNA activates dendritic cells via toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice

被引:157
|
作者
Spies, B [1 ]
Hochrein, H [1 ]
Vabulas, M [1 ]
Huster, K [1 ]
Busch, DH [1 ]
Schmitz, F [1 ]
Heit, A [1 ]
Wagner, H [1 ]
机构
[1] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 171卷 / 11期
关键词
D O I
10.4049/jimmunol.171.11.5908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We analyzed whether the immunobiology of vaccinating plasmid DNA containing a transcription unit for OVA is influenced by immunostimulatory CpG motifs in the plasmid backbone. Indeed, plasmid DNA differentially activated in vitro myeloid and plasmacytoid dendritic cells (DCs) provided they expressed the CpG-DNA receptor, Toll-like receptor 9 (TLR9). Dependent on the DC subset, activation resulted in type 1 IFN production, while both DC subsets produced IL-6 and up-regulated expression of costimulatory molecules CD40 and CD86. In vivo, however, even upon repeated vaccination with plasmid DNA, priming of OVA-specific CTL and clonal expansion of SIINFEKL-specific CD8 T cells were equal in TLR9-positive and TLR9- or MyD88-negative mice. Overall, these results negate a dominant role of CpG-DNA/TLR9 interactions in long-term vaccination protocols.
引用
收藏
页码:5908 / 5912
页数:5
相关论文
共 50 条
  • [41] Toll-like Receptor 9 (TLR9) Plays a Key Role in the Autonomic Cardiac and Baroreflex Control of Arterial Pressure
    Rodrigues, Fernanda L.
    Bomfim, Gisele F.
    Silva, Carlos A.
    Fazan Jr, Rubens
    Tostes, Rita C.
    Carneiro, Fernando S.
    HYPERTENSION, 2013, 62 (03)
  • [42] Toll-Like Receptor 9 (TLR9) Inhibition Attenuates Chronic Stress-Induced Social Behavior Deficits
    Jose, Dania
    Madeshiya, Amit Kumar
    Tripathi, Ashutosh
    Todd, Tela
    Quevedo, Joao
    Pillai, Anilkumar
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S180 - S180
  • [43] Selectively targeting the toll-like receptor 9 (TLR9) - IRF 7 signaling pathway by polymer blend particles
    Chen, Helen C.
    Zhan, Xi
    Tran, Kenny K.
    Shen, Hong
    BIOMATERIALS, 2013, 34 (27) : 6464 - 6472
  • [44] Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma
    Karime, Christian
    Wang, Jing
    Woodhead, Gregory
    Mody, Kabir
    Hennemeyer, Charles T.
    Borad, Mitesh J.
    Mahadevan, Daruka
    Chandana, Sreenivasa R.
    Babiker, Hani
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (01) : 1 - 13
  • [45] The role of toll-like receptor 9 (TLR9) in Epstein-Barr virus-associated gastric cancer
    Dworzanska, Anna
    Strycharz-Dudziak, Malgorzata
    Dworzanski, Jakub
    Stec, Agnieszka
    Rajtar, Barbara
    Drop, Bartlomiej
    Polz-Dacewicz, Malgorzata
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2020, 33 (02) : 106 - 111
  • [46] Toll-Like Receptor-9 (TLR9) is Requisite for Acute Inflammatory Response and Injury Following Lung Contusion
    Suresh, Madathilparambil V.
    Thomas, Bivin
    Dolgachev, Vladislav A.
    Sherman, Matthew A.
    Goldberg, Rebecca
    Johnson, Mark
    Chowdhury, Aulina
    Machado-Aranda, David
    Raghavendran, Krishnan
    SHOCK, 2016, 46 (04): : 412 - 419
  • [47] Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9
    Ito, T
    Wang, YH
    Liu, YJ
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2005, 26 (03): : 221 - 229
  • [48] A TOLL-LIKE RECEPTOR 9 (TLR9) SINGLE NUCLEOTIDE POLYMORPHISM MAY INCREASE COMPLICATIONS TO HELICOBACTER PYLORI INFECTION
    Balogun, Rilwan
    Ding, Lin
    Mallick, Palash
    Borgstrom, Mark
    Gavini, Hemanth K.
    Leal, Rolando J.
    Taleban, Sasha
    Babaria, Radhika
    Merchant, Juanita L.
    GASTROENTEROLOGY, 2023, 164 (06) : S801 - S801
  • [49] Toll-like receptor 9 (TLR9) activation by CpG or pDNA ameliorates hepatic fibrosis associated with lymphocyte alterations
    Axelrod, Jonathan H.
    Khvalevsky, Elena
    Doron, Sarit
    Enk, Jonathan
    Melhem, Alaa
    Nechemia, Yael
    Pappo, Orit
    Haj, Madi
    Galun, Eithan
    Safadi, Rifaat
    HEPATOLOGY, 2006, 44 (04) : 575A - 575A
  • [50] Toll-like receptor 9 (TLR9) interacts with ErbB receptors at membrane level and a TLR9 agonist synergizes with trastuzumab in trastuzumab-resistant breast cancer xenografts via modulation of ErbB signalling
    Tortora, Giampaolo
    Garofalo, Sonia
    Caputo, Rosa
    Bianco, Roberto
    Rosa, Roberta
    Gelardi, Teresa
    Merola, Gerardina
    Racioppi, Luigi
    Garbi, Corrado
    Kandimalla, Ekambar
    Agrawal, Sudhir
    Damiano, Vincenzo
    CANCER RESEARCH, 2009, 69